Home LiteratureArticle Details
PMID: 14966564 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Inhibition of airway remodeling in IL-5-deficient mice.

The Journal of clinical investigation ·Vol. 113 ·No. 4 ·2004-02-00 ·Pages 551-60

Cho JY, Miller M, Baek KJ, Han JW, Nayar J, Lee SY, McElwain K, McElwain S, Friedman S, Broide DH

Abstract

To determine the role of IL-5 in airway remodeling, IL-5-deficient and WT mice were sensitized to OVA and challenged by repetitive administration of OVA for 3 months. IL-5-deficient mice had significantly less peribronchial fibrosis (total lung collagen content, peribronchial collagens III and V) and significantly less peribronchial smooth muscle (thickness of peribronchial smooth muscle layer, alpha-smooth muscle actin immunostaining) compared with WT mice challenged with OVA. WT mice had a significant increase in the number of peribronchial cells staining positive for major basic protein and TGF-beta. In contrast, IL-5-deficient mice had a significant reduction in the number of peribronchial cells staining positive for major basic protein, which was paralleled by a similar reduction in the number of cells staining positive for TGF-beta, suggesting that eosinophils are a significant source of TGF-beta in the remodeled airway. OVA challenge induced significantly higher levels of airway epithelial alphaVbeta6 integrin expression, as well as significantly higher levels of bioactive lung TGF-beta in WT compared with IL-5-deficient mice. Increased airway epithelial expression of alphaVbeta6 integrin may contribute to the increased activation of latent TGF-beta. These results suggest an important role for IL-5, eosinophils, alphaVbeta6, and TGF-beta in airway remodeling.

MeSH Terms
Animals Antigens, Neoplasm/metabolism Bronchial Provocation Tests Bronchoalveolar Lavage Fluid/cytology Eosinophils/immunology,metabolism Humans Integrins/metabolism Interleukin-5/genetics,metabolism Mice Mice, Knockout Ovalbumin/administration & dosage,immunology Pulmonary Fibrosis/immunology,pathology Respiratory Mucosa/cytology,metabolism,pathology Respiratory System/anatomy & histology,immunology,metabolism,pathology Transforming Growth Factor beta/metabolism
Chemicals
Antigens, Neoplasm Integrins Interleukin-5 Transforming Growth Factor beta integrin alphavbeta6 Ovalbumin
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Cho Jae Youn
Department of Medicine, University of California San Diego, La Jolla, California 92093-0635, USA.
Miller Marina
Baek Kwang Je
Han Ji Won
Nayar Jyothi
Lee Sook Young
McElwain Kirsti
McElwain Shauna
Friedman Stephanie
Broide David H
References (34)
34 references, click to expand
  1. Role of transforming growth factor beta in human disease.
    N Engl J Med. 2000 May 4;342(18):1350-8 PMID: 10793168
  2. Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma.
    Lab Invest. 2000 May;80(5):655-62 PMID: 10830775
  3. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody.
    Am J Respir Cell Mol Biol. 2000 Aug;23(2):241-6 PMID: 10919992
  4. Activation and transforming growth factor-beta production in eosinophils by hyaluronan.
    Am J Respir Cell Mol Biol. 2000 Oct;23(4):444-51 PMID: 11017908
  5. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.
    Lancet. 2000 Dec 23-30;356(9248):2144-8 PMID: 11191542
  6. Airway smooth muscle cell proliferation is increased in asthma.
    Am J Respir Crit Care Med. 2001 Aug 1;164(3):474-7 PMID: 11500353
  7. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).
    J Exp Med. 2001 Sep 17;194(6):809-21 PMID: 11560996
  8. Fast flowing eosinophils: signals for stopping and stepping out of blood vessels.
    Am J Respir Cell Mol Biol. 2002 Jun;26(6):637-40 PMID: 12034560
  9. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.
    J Exp Med. 2002 Jun 3;195(11):1433-44 PMID: 12045241
  10. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin.
    J Immunol. 2002 Oct 15;169(8):4604-12 PMID: 12370399
  11. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.
    Am J Respir Crit Care Med. 2003 Jan 15;167(2):199-204 PMID: 12406833
  12. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse.
    J Immunol. 2003 Mar 15;170(6):3296-305 PMID: 12626589
  13. Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids.
    Am J Respir Cell Mol Biol. 2003 Jun;28(6):655-63 PMID: 12760963
  14. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.
    J Clin Invest. 2003 Oct;112(7):1029-36 PMID: 14523040
  15. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences.
    J Immunol. 2003 Nov 1;171(9):4860-7 PMID: 14568966
  16. Recombinant human interleukin 5 is a selective activator of human eosinophil function.
    J Exp Med. 1988 Jan 1;167(1):219-24 PMID: 2826636
  17. Subepithelial fibrosis in the bronchi of asthmatics.
    Lancet. 1989 Mar 11;1(8637):520-4 PMID: 2466184
  18. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.
    N Engl J Med. 1992 Jan 30;326(5):298-304 PMID: 1530827
  19. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics.
    J Clin Invest. 1992 Oct;90(4):1414-24 PMID: 1401075
  20. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling.
    J Cell Sci. 1995 Jun;108 ( Pt 6):2241-51 PMID: 7673344
  21. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma.
    J Allergy Clin Immunol. 1995 Nov;96(5 Pt 1):661-8 PMID: 7499683
  22. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.
    J Exp Med. 1996 Jan 1;183(1):109-17 PMID: 8551213
  23. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.
    J Exp Med. 1996 Jan 1;183(1):195-201 PMID: 8551223
  24. Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin.
    J Cell Biol. 1996 May;133(4):921-8 PMID: 8666675
  25. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation.
    Am J Respir Cell Mol Biol. 1996 Sep;15(3):404-9 PMID: 8810646
  26. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization.
    Am J Respir Crit Care Med. 1997 Mar;155(3):819-25 PMID: 9117011
  27. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma.
    J Exp Med. 1997 Jun 16;185(12):2143-56 PMID: 9182686
  28. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma.
    Am J Respir Cell Mol Biol. 1997 Sep;17(3):326-33 PMID: 9308919
  29. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics.
    Am J Respir Crit Care Med. 1998 Jan;157(1):204-9 PMID: 9445301
  30. Eosinophilia.
    N Engl J Med. 1998 May 28;338(22):1592-600 PMID: 9603798
  31. IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils.
    J Immunol. 1998 Jun 15;160(12):6121-7 PMID: 9637529
  32. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.
    Cell. 1999 Feb 5;96(3):319-28 PMID: 10025398
  33. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness.
    Am J Respir Crit Care Med. 1999 Sep;160(3):934-41 PMID: 10471622
  34. Airway remodeling in asthma.
    J Clin Invest. 1999 Oct;104(8):1001-6 PMID: 10525034
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
2004-02-00
Pages
551-60
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC338264
Subset
IM
Grants
NIAID NIH HHS · R01 AI038425 · United States
NIAID NIH HHS · R37 AI038425 · United States
NIAID NIH HHS · AI-33977 · United States
NIAID NIH HHS · AI-38425 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com